E. M. Glenn

1.2k total citations
40 papers, 911 citations indexed

About

E. M. Glenn is a scholar working on Pharmacology, Endocrinology, Diabetes and Metabolism and Organic Chemistry. According to data from OpenAlex, E. M. Glenn has authored 40 papers receiving a total of 911 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pharmacology, 9 papers in Endocrinology, Diabetes and Metabolism and 6 papers in Organic Chemistry. Recurrent topics in E. M. Glenn's work include Inflammatory mediators and NSAID effects (8 papers), Hormonal Regulation and Hypertension (6 papers) and Adrenal Hormones and Disorders (5 papers). E. M. Glenn is often cited by papers focused on Inflammatory mediators and NSAID effects (8 papers), Hormonal Regulation and Hypertension (6 papers) and Adrenal Hormones and Disorders (5 papers). E. M. Glenn collaborates with scholars based in United States and United Kingdom. E. M. Glenn's co-authors include Don H. Nelson, N. A. Rohloff, Barbara J. Bowman, David G. Kaiser, Stanley C. Lyster, Jack E. Gray, Robert J. Seely, Robert Bayer, Curtis E. Meyer and Frank H. Tyler and has published in prestigious journals such as Nature, Journal of Clinical Investigation and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

E. M. Glenn

39 papers receiving 733 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
E. M. Glenn United States 17 207 181 159 154 107 40 911
S. L. Steelman United States 19 443 2.1× 270 1.5× 139 0.9× 91 0.6× 91 0.9× 49 1.4k
Neil R. Ackerman United States 15 156 0.8× 170 0.9× 235 1.5× 156 1.0× 47 0.4× 34 912
Shinichiro Hirai Japan 13 109 0.5× 361 2.0× 90 0.6× 126 0.8× 74 0.7× 20 1.3k
M Hichens United States 27 327 1.6× 631 3.5× 184 1.2× 133 0.9× 107 1.0× 52 1.9k
G. W. Oertel Germany 16 464 2.2× 388 2.1× 66 0.4× 68 0.4× 87 0.8× 158 1.1k
Jürgen Sandow Germany 15 207 1.0× 208 1.1× 47 0.3× 91 0.6× 60 0.6× 24 1.0k
G. O. Potts United States 17 311 1.5× 252 1.4× 40 0.3× 187 1.2× 73 0.7× 47 978
J. Rosenthaler Japan 16 95 0.5× 198 1.1× 80 0.5× 52 0.3× 87 0.8× 32 788
T Lubrano United States 16 156 0.8× 432 2.4× 517 3.3× 48 0.3× 69 0.6× 33 1.3k
Leonard J. Lerner Malaysia 15 189 0.9× 232 1.3× 96 0.6× 80 0.5× 54 0.5× 49 1.0k

Countries citing papers authored by E. M. Glenn

Since Specialization
Citations

This map shows the geographic impact of E. M. Glenn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. M. Glenn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. M. Glenn more than expected).

Fields of papers citing papers by E. M. Glenn

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. M. Glenn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. M. Glenn. The network helps show where E. M. Glenn may publish in the future.

Co-authorship network of co-authors of E. M. Glenn

This figure shows the co-authorship network connecting the top 25 collaborators of E. M. Glenn. A scholar is included among the top collaborators of E. M. Glenn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. M. Glenn. E. M. Glenn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Goddard, CA, R. Ratcliff, E. M. Glenn, et al.. (1997). A second dose of a CFTR cDNA–liposome complex is as effective as the first dose in restoring cAMP-dependent chloride secretion to null CF mice trachea. Gene Therapy. 4(11). 1231–1236. 26 indexed citations
2.
Skulnick, Harvey I., James H. Ludens, Michael G. Wendling, et al.. (1986). Pyrimidinones. 3. N-Substituted 6-phenylpyrimidinones and pyrimidinediones with diuretic/hypotensive and antiinflammatory activity. Journal of Medicinal Chemistry. 29(8). 1499–1504. 33 indexed citations
3.
Seely, Robert J. & E. M. Glenn. (1978). Salbutamol as a Topical Anti-inflammatory Drug. Experimental Biology and Medicine. 159(2). 223–225. 2 indexed citations
4.
Glenn, E. M., N. A. Rohloff, Barbara J. Bowman, & Stanley C. Lyster. (1973). The pharmacology of 2-(2-fluoro-4-biphenylyl)Propionic acid (Flurbiprofen) A potent non-steroidal anti-inflammatory drug. Inflammation Research. 3(4). 210–216. 28 indexed citations
5.
Kaiser, David G. & E. M. Glenn. (1972). Correlation of Plasma 4,5-Bis (p-methoxyphenyl)-2-phenylpyrrole-3- acetonitrile Levels with Biological Activity. Journal of Pharmaceutical Sciences. 61(12). 1908–1911. 48 indexed citations
6.
Glenn, E. M., et al.. (1971). Aggregation of Red Cells and Effects of Nonsteroidal Anti-inflammatory Drugs. Experimental Biology and Medicine. 138(1). 235–240. 7 indexed citations
7.
Glenn, E. M., Stanley C. Lyster, & N. A. Rohloff. (1969). Induction of Inflammation, Fever, and Acceleration of Adjuvant-Disease by Surfactants. Experimental Biology and Medicine. 130(1). 110–115. 2 indexed citations
8.
Perper, R. J., et al.. (1969). Separation of Anti-inflammatory and Immunosuppressive Activities in Heterologous Antilymphocyte Serum. Nature. 223(5201). 86–87. 12 indexed citations
9.
Glenn, E. M.. (1969). Fibrinogen and experimental inflammation. Biochemical Pharmacology. 18(2). 317–326. 26 indexed citations
10.
Glenn, E. M., et al.. (1969). In Vitro Effects of Non-steroidal Anti-inflammatory Drugs (NAIFD). Experimental Biology and Medicine. 130(4). 1327–1332. 8 indexed citations
11.
Glenn, E. M.. (1968). Inhibition of Adjuvant-Induced Polyarthritis with Cytarabine. Experimental Biology and Medicine. 129(3). 860–865. 5 indexed citations
12.
Glenn, E. M., et al.. (1967). THE PHARMACOLOGY OF 2,3-BIS-(p-METHOXYPHENYL)-INDOLE (INDOXOLE). Journal of Pharmacology and Experimental Therapeutics. 155(1). 157–166. 22 indexed citations
13.
Kaiser, David G., E. M. Glenn, R.H. Johnson, & Richard L. Johnston. (1967). CORRELATION OF SERUM INDOXOLE [2,3-BIS(p-METHOXYPHENYL)-INDOLE] LEVELS WITH BIOLOGIC ACTIVITY. Journal of Pharmacology and Experimental Therapeutics. 155(1). 174–180. 9 indexed citations
14.
Szmuszkovicz, Jacob, et al.. (1966). Synthesis and Antiinflammatory Activity of 2,3-Bis(p-methoxyphenyl)indole and Related Compounds. Journal of Medicinal Chemistry. 9(4). 527–536. 36 indexed citations
15.
Glenn, E. M., Sara Richardson, & Barbara J. Bowman. (1959). A METHOD OF ASSAY OF ANTITUMOR ACTIVITY USING A RAT MAMMARY FIBROADENOMA. Endocrinology. 64(3). 379–389. 2 indexed citations
16.
Glenn, E. M.. (1959). IN VITRO AND IN VIVOMETABOLISM OF PREDNISOLONE: STUDIES CONCERNING ITS BIOLOGICAL EFFECTIVENESS. Endocrinology. 64(3). 373–378. 7 indexed citations
17.
Glenn, E. M., et al.. (1959). POTENTIATION OF BIOLOGICAL ACTIVITIES OF STEROIDS BY CARCINOGENIC HYDROCARBONS. Endocrinology. 64(3). 419–430. 7 indexed citations
18.
Glenn, E. M., et al.. (1957). RELATION BETWEEN BIOLOGICAL ACTIVITY OF HYDROCORTISONE ANALOGUES AND THEIR RATES OF INACTIVATION BY RAT LIVER ENZYME SYSTEMS. Endocrinology. 61(2). 128–142. 53 indexed citations
19.
Recknagel, Richard O. & E. M. Glenn. (1955). Enzymatic Degradation of Side-Chain of Cortisone: Intracellular Localization of the Enzyme System.. Experimental Biology and Medicine. 89(1). 156–159. 2 indexed citations
20.
Sandberg, Avery A., Don H. Nelson, E. M. Glenn, Frank H. Tyler, & Leo T. Samuels. (1953). 17-HYDR0XYC0RTIC0STER0IDS AND 17-KETOSTEROIDS IN URINE OF HUMAN SUBJECTS: CLINICAL APPLICATION OF A METHOD EMPLOYING β-GLUCURONIDASE HYDROLYSIS*. The Journal of Clinical Endocrinology & Metabolism. 13(12). 1445–1464. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by S. L. Steelman Breakdown of academic impact, for papers by Neil R. Ackerman Breakdown of academic impact, for papers by Shinichiro Hirai Breakdown of academic impact, for papers by M Hichens Breakdown of academic impact, for papers by G. W. Oertel Breakdown of academic impact, for papers by Jürgen Sandow Breakdown of academic impact, for papers by G. O. Potts Breakdown of academic impact, for papers by J. Rosenthaler Breakdown of academic impact, for papers by T Lubrano Breakdown of academic impact, for papers by Leonard J. Lerner
Rankless by CCL
2026